Biomanufacturing process for the production of bacteriocins from Bacillaceae family

Ahmad Firdaus B. Lajis

Bioresources and Bioprocessing ›› 2020, Vol. 7 ›› Issue (1) : 8

PDF
Bioresources and Bioprocessing ›› 2020, Vol. 7 ›› Issue (1) : 8 DOI: 10.1186/s40643-020-0295-z
Review

Biomanufacturing process for the production of bacteriocins from Bacillaceae family

Author information +
History +
PDF

Abstract

Members of Bacillaceae family are of major interest in medical industry due to vast antimicrobial peptides they produce as therapeutic agents. For decades, synthetic and natural occurring antibiotics have been used to treat infectious diseases, but heavy dependence on these drugs has led to significant drawbacks which propel continuous development of new antibiotics generation. Recent findings have shown several bacteriocins of Bacillaceae as promising alternatives to the conventional drugs to combat the emergence of new drug-resistant pathogens. In this present review, Bacillaceae bacteriocins’ classification such as lantibiotics and thiazole/oxazole-modified microcins as well as their biochemical characterization such as sensitivity to enzymes, temperature, pH and chemicals are described. This article enlightens on the medical application of several Bacillaceae bacteriocins emphasizing those that underwent and on-going preclinical trials. This review also discusses the development of Bacillaceae bacteriocins production, focusing strains selection and fermentation factors such as inocula size, medium (carbon, nitrogen, minerals sources), temperature, pH, agitation and aeration rate, dissolved oxygen tension (DOT), fermentation time, inducers and mode of operation via various statistical methods for their optimization. It also highlights recent advance in the production of bioengineered and recombinant bacteriocins in bioreactors system which are rarely disclosed in literature.

Keywords

Antimicrobial peptide / Bacillus sp. / Fermentation / Lantibiotic / Preclinical trial / Recombinant fusion

Cite this article

Download citation ▾
Ahmad Firdaus B. Lajis. Biomanufacturing process for the production of bacteriocins from Bacillaceae family. Bioresources and Bioprocessing, 2020, 7(1): 8 DOI:10.1186/s40643-020-0295-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Alam SI, Kamran M, Sohail M, . Partial characterization of bacteriocin like inhibitory substance from Bacillus BS15, a local soil isolate. Pak J Bot, 2011, 43: 2195-2199.

[2]

Algburi A, Volski A, Chikindas ML. Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli. Pathog Dis, 2015, 73: 1-12.

[3]

An J, Zhu W, Liu Y, . Purification and characterization of a novel bacteriocin CAMT2 produced by Bacillus amyloliquefaciens isolated from marine fish Epinephelus areolatus. Food Control, 2015, 51: 278-282.

[4]

Ansari A, Zohra RR, Tarar OM, . Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA). BMC Microbiol, 2018, 18: 192.

[5]

Antal K, Balikó G, Chuluunbaatar T, . Cloning and characterization of the DNA region responsible for megacin A-216 production in Bacillus megaterium 216. J Bacteriol, 2008, 190: 6448-6457.

[6]

Anthony T, Rajesh T, Kayalvizhi N, Gunasekaran P. Influence of medium components and fermentation conditions on the production of bacteriocin(s) by Bacillus licheniformis AnBa9. Bioresour Technol, 2009, 100: 872-877.

[7]

Arias AA, Ongena M, Devreese B, . Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1. PLoS ONE, 2013, 8: e83037.

[8]

Ayed HB, Maalej H, Hmidet N, Nasri M. Isolation and biochemical characterisation of a bacteriocin-like substance produced by Bacillus amyloliquefaciens An6. J Glob Antimicrob Resist, 2015, 3: 255-261.

[9]

Baindara P, Chaudhry V, Mittal G, . Characterization of the antimicrobial peptide penisin, a class Ia novel lantibiotic from Paenibacillus sp. strain A3. Antimicrob Agents Chemother, 2015, 60: 580-591.

[10]

Baindara P, Singh N, Ranjan M, . Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens. Microbiology, 2016, 162: 1286-1299.

[11]

Baindara P, Gautam A, Raghava GPS, Korpole S. Anticancer properties of a defensin like class IId bacteriocin laterosporulin 10. Sci Rep, 2017, 7: 46541.

[12]

Barbosa J, Caetano T, Mendo S. Class I and Class II lanthipeptides produced by Bacillus spp. J Nat Prod, 2015, 78: 2850-2866.

[13]

Basi-Chipalu S, Dischinger J, Josten M, . Pseudomycoicidin, a class II lantibiotic from Bacillus pseudomycoides. Appl Environ Microbiol, 2015, 81: 3419-3429.

[14]

Bastos MC, Lívio M, Coelho V, . Resistance to bacteriocins produced by Gram-positive bacteria. Microbiology, 2017, 161: 683-700.

[15]

Begley M, Cotter PD, Hill C, Ross RP. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol, 2009, 75: 5451-5460.

[16]

Bochmann SM, Spieß T, Kötter P, Entian K-D. Synthesis and succinylation of subtilin-like lantibiotics are strongly influenced by glucose and transition state regulator AbrB. Appl Environ Microbiol, 2015, 81: 614-622.

[17]

Böttiger T, Schneider T, Martínez B, . Influence of Ca2+ ions on the activity of Lantibiotics containing a Mersacidin-like lipid II binding motif. Appl Environ Microbiol, 2009, 75: 4427-4434.

[18]

Cavera VL, Volski A, Chikindas ML. The natural antimicrobial subtilosin A synergizes with lauramide arginine ethyl ester (LAE), ε-poly-l-lysine (polylysine), clindamycin phosphate and metronidazole, against the vaginal pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins, 2015, 7: 164-171.

[19]

Cherif A, Rezgui W, Raddadi N, . Characterization and partial purification of entomocin 110, a newly identified bacteriocin from Bacillus thuringiensis subsp. Entomocidus HD110. Microbiol Res, 2008, 163: 684-692.

[20]

Chhetri V, Prakitchaiwattana C, Settachaimongkon S. A potential protective culture; halophilic Bacillus isolates with bacteriocin encoding gene against Staphylococcus aureus in salt added foods. Food Control, 2019, 104: 292-299.

[21]

Chopra L, Singh G, Choudhary V, Sahoo DK. Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93. Appl Environ Microbiol, 2014, 80: 2981-2990.

[22]

Cladera-Olivera F, Caron GR, Brandelli A. Bacteriocin production by Bacillus licheniformis strain P40 in cheese whey using response surface methodology. Biochem Eng J, 2004, 21: 53-58.

[23]

Collins FWJ, O’Connor PM, O’Sullivan O, . Formicin—a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576. Microbiology, 2016, 162: 1662-1671.

[24]

Compaoré CS, Nielsen DS, Ouoba LII, . Co-production of surfactin and a novel bacteriocin by Bacillus subtilis subsp. subtilis H4 isolated from Bikalga, an African alkaline Hibiscus sabdariffa seed fermented condiment. Int J Food Microbiol, 2013, 162: 297-307.

[25]

Cotter PD, Ross RP, Hill C. Bacteriocins—a viable alternative to antibiotics?. Nat Rev Microbiol, 2012, 11: 95-105.

[26]

Dehghanifar S, Keyhanfar M, Emtiazi G. Production and partial purification of thermostable bacteriocins from Bacillus pumilus ZED17 and DFAR8 strains with antifungal activity. Mol Biol Res Commun, 2019, 8: 41-49.

[27]

Dischinger J, Josten M, Szekat C, . Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS ONE, 2009, 4: e6788.

[28]

Dominguez APM, Bizani D, Cladera-Olivera F, Brandelli A. Cerein 8A production in soybean protein using response surface methodology. Biochem Eng J, 2007, 35: 238-243.

[29]

Dreyer L, Smith C, Deane SM, . Migration of bacteriocins across gastrointestinal epithelial and vascular endothelial cells, as determined using in vitro simulations. Sci Rep, 2019

[30]

Embaby AM, Heshmat Y, Hussein A, Marey HS. A sequential statistical approach towards an optimized production of a broad spectrum bacteriocin substance from a soil bacterium Bacillus sp. YAS 1 Strain. Sci World J, 2014

[31]

Field D, Cotter PD, Hill C, Ross RP. Bioengineering lantibiotics for therapeutic success. Front Microbiol, 2015, 6: 1363.

[32]

Flühe L, Knappe TA, Gattner MJ, . The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A. Nat Chem Biol, 2012, 8: 350-357.

[33]

Fuchs SW, Jaskolla TW, Bochmann S, . Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029 T with high antimicrobial activity. Appl Environ Microbiol, 2011, 77: 1698-1707.

[34]

Gabrielsen C, Brede DA, Nes IF, Diep DB. Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol, 2014, 80: 6854-6862.

[35]

Garg N, Tang W, Goto Y, . Lantibiotics from Geobacillus thermodenitrificans. Proc Natl Acad Sci USA, 2012, 109: 5241-5246.

[36]

Garg N, Oman TJ, Andrew Wang T-S, . Mode of action and structure-activity relationship studies of geobacillin I. J Antibiot, 2014, 67: 133-136.

[37]

Ge J, Kang J, Ping W. Effect of acetic acid on bacteriocin production by gram-positive bacteria. J Microbiol Biotechnol, 2019, 29: 1341-1348.

[38]

Geiger C, Spieß T, Korn SM, . Specificity of subtilin-mediated activation of histidine kinase SpaK. Appl Environ Microbiol, 2017, 83: e00781-17.

[39]

Ghanbari M, Rezaei M, Soltani M, . Production of bacteriocin by a novel Bacillus sp. strain RF 140, an intestinal bacterium of Caspian Frisian Roach (Rutilus frisii kutum). Iran J Vet Res, 2009, 10: 267-272.

[40]

Goto Y, Li B, Claesen J, . Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol, 2010, 8: e1000339.

[41]

Halimi B, Dortu C, Arguelles-Arias A, . Antilisterial activity on poultry meat of amylolysin, a bacteriocin from Bacillus amyloliquefaciens GA1. Probiotics Antimicrob Proteins, 2010, 2: 120-125.

[42]

Hammami I, Triki MA, Rebai A. Purification and characterization of the novel bacteriocin Bac IH7 with antifungal and antibacterial properties. J Plant Pathol, 2011, 93: 443-454.

[43]

Hanafy AM, Al-Mutairi AA, Al-Reedy RM, . Phylogenetic affiliations of Bacillus amyloliquefaciens isolates produced by a bacteriocin-like substance in goat milk. Integr Med Res, 2016, 10: 631-641.

[44]

Hatcher N, Moon S, Wolf JR. Partial characterization of a novel bacteriocin from Bacillus cereus GS1, a soil isolate. J Ky Acad Sci, 2015, 75: 37-46.

[45]

He L, Chen W, Liu Y. Production and partial characterization of bacteriocin-like peptides by Bacillus licheniformis ZJU12. Microbiol Res, 2006, 161: 321-326.

[46]

He Z, Kisla D, Zhang L, . Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin. Appl Environ Microbiol, 2007, 73: 168-178.

[47]

Herzner AM, Dischinger J, Szekat C, . Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42. PLoS ONE, 2011, 6: e22389.

[48]

Huang E, Yousef AE. Biosynthesis of paenibacillin, a lantibiotic with N-terminal acetylation, by Paenibacillus polymyxa. Microbiol Res, 2015, 181: 15-21.

[49]

Huang T, Zhang X, Pan J, . Purification and characterization of a novel cold shock protein-like bacteriocin synthesized by Bacillus thuringiensis. Sci Rep, 2016, 6: 35560.

[50]

Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bacteriocin-like inhibitory substance produced. J Appl Microbiol, 1998, 85: 42-50.

[51]

Islam MR, Nagao J-I, Zendo T, Sonomoto K. Antimicrobial mechanism of lantibiotics. Biochem Soc Trans, 2012, 40: 1528-1533.

[52]

Jarrett JT. The biosynthesis of thiol-and thioether-containing cofactors and secondary metabolites catalyzed by radical s-adenosylmethionine enzymes. J Biol Chem, 2014, 290: 3972-3979.

[53]

Joseph B, Dhas B, Hena V, . Bacteriocin from Bacillus subtilis as a novel drug against diabetic foot ulcer bacterial pathogens. Asian Pac J Trop Biomed, 2013, 3: 942-946.

[54]

Kaboré D, Sandris Nielsen D, Sawadogo-Lingani H, . Inhibition of Bacillus cereus growth by bacteriocin producing Bacillus subtilis isolated from fermented baobab seeds (maari) is substrate dependent. Int J Food Microbiol, 2013, 162: 114-119.

[55]

Kaewklom S, Lumlert S, Kraikul W, Aunpad R. Control of Listeria monocytogenes on sliced bologna sausage using a novel bacteriocin, amysin, produced by Bacillus amyloliquefaciens isolated from Thai shrimp paste (Kapi). Food Control, 2013, 32: 552-557.

[56]

Kawulka KE, Sprules T, Diaper CM, . Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to α-carbon cross-links: formation and reduction of α-thio-α-amino acid derivatives. Biochemistry, 2004, 43: 3385-3395.

[57]

Kayalvizhi N, Gunasekaran P. Purification and characterization of a novel broad-spectrum bacteriocin from Bacillus licheniformis MKU3. Biotechnol Bioprocess Eng, 2010, 15: 365-370.

[58]

Khatri I, Sharma S, Ramya TN, Subramanian S. Complete genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, two phylogenetically distinct probiotics. PLoS One, 2016, 11(6): e0156745.

[59]

Khochamit N, Siripornadulsil S, Sukon P, Siripornadulsil W. Antibacterial activity and genotypic–phenotypic characteristics of bacteriocin-producing Bacillus subtilis KKU213: potential as a probiotic strain. Microbiol Res, 2015, 170: 36-50.

[60]

Kim Y-O, Park I-S, Kim D-J, . Identification and characterization of a bacteriocin produced by an isolated Bacillus sp. SW1-1 that exhibits antibacterial activity against fish pathogens. J Korean Soc Appl Biol Chem, 2014, 57: 605-612.

[61]

Kindoli S, Lee HA, Heo K, Kim JH. Properties of a bacteriocin from Bacillus subtilis H27 isolated from Cheonggukjang. Food Sci Biotechnol, 2012, 21: 1745-1751.

[62]

Kobayashi T, Agustini TW, Ibrahim R, . Production of bacteriocin by Virgibacillus salexigens isolated from “terasi”: a traditionally fermented shrimp paste in Indonesia. World J Microbiol Biotechnol, 2016, 32: 47.

[63]

Kurata A, Yamaguchi T, Kira M, Kishimoto N. Characterization and heterologous expression of an antimicrobial peptide from Bacillus amyloliquefaciens CMW1. Biotechnol Biotechnol Equip, 2019, 33: 886-893.

[64]

Lawton EM, Cotter PD, Hill C, Ross RP. Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett, 2007, 267: 64-71.

[65]

Lee HA, Hwan Kim J. Properties of bac W42, a bacteriocin produced by Bacillus subtilis W42 isolated from Cheonggukjang. J Microbiol Biotechnol, 2012, 22: 1092-1100.

[66]

Lee K-H, Jun K-D, Kim W-S, Paik H-D. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett Appl Microbiol, 2001, 32: 146-151.

[67]

Leite JA, Tulini FL, dos Reis-Teixeira FB, . Bacteriocin-like inhibitory substances (BLIS) produced by Bacillus cereus: preliminary characterization and application of partially purified extract containing BLIS for inhibiting Listeria monocytogenes in pineapple pulp. LWT Food Sci Technol, 2016, 72: 261-266.

[68]

Lim KB, Balolong MP, Hoon Kim S, . Isolation and characterization of a broad spectrum bacteriocin from Bacillus amyloliquefaciens RX7. Biomed Res Int, 2016, 2016: 8521476.

[69]

Liu Z, Budiharjo A, Wang P, . The highly modified microcin peptide plantazolicin is associated with nematicidal activity of Bacillus amyloliquefaciens FZB42. Appl Microbiol Biotechnol, 2013, 97: 10081-10090.

[70]

Liu X, Lee JY, Jeong S-J, . Properties of a bacteriocin produced by Bacillus subtilis EMD4 isolated from Ganjang (Soy Sauce). J Microbiol Biotechnol, 2015, 25: 1493-1501.

[71]

Lohans CT, Vederas JC. Structural characterization of thioether-bridged bacteriocins. J Antibiot, 2014, 67: 23-30.

[72]

Luca M, Mario V, Gino N, De Felice M. Purification and partial characterization of bacillocin 490, a novel bacteriocin produced by a thermophilic strain of Bacillus licheniformis. Microb Cell Fact, 2002, 91: 1-5.

[73]

Maria T, Ilias F, Gerda K, Antigoni M. Partial purification and characterization of a bacteriocin produced by Bacillus subtilis NCIMB 3610 that exhibits antimicrobial activity against fish pathogens. J Biol Res, 2012, 18: 310-319.

[74]

Martínez-Cardeñas JA, De La Fuente-Salcido NM, Salcedo-Hernández R, . Effects of physical culture parameters on bacteriocin production by Mexican strains of Bacillus thuringiensis after cellular induction. J Ind Microbiol Biotechnol, 2012, 39: 183-189.

[75]

Martin-Visscher LA, van Belkum MJ, Vederas JC. Class IIc or circular bacteriocins. Prokaryotic antimicrobial peptides, 2011, New York: Springer, 213-236.

[76]

Mathur H, Fallico V, O’Connor PM, . Insights into the mode of action of the sactibiotic thuricin CD. Front Microbiol, 2017, 8: 696.

[77]

McAuliffe O, Ross RP, Hill C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev, 2001, 25: 285-308.

[78]

Mickymaray S, Alturaiki W, Al-Aboody MS, . Anti-bacterial efficacy of bacteriocin produced by marine Bacillus subtilis against clinically important extended spectrum beta-lactamase strains and methicillin-resistant Staphylococcus aureus. Int J Med Res Health Sci, 2018, 7: 75-83.

[79]

Motta AS, Brandelli A. Evaluation of environmental conditions for production of bacteriocin-like substance by Bacillus sp. strain P34. World J Microbiol Biotechnol, 2008, 24: 641-646.

[80]

Murphy K, O’Sullivan O, Rea MC, . Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS ONE, 2011, 6: e20852.

[81]

Nagao J, Nishie M, Sonomoto K. Methodologies and strategies for the bioengineering of lantibiotics. Curr Pharm Biotechnol, 2011, 12: 1221-1230.

[82]

Ovchinnikov KV, Chi H, Mehmeti I, . Novel group of leaderless multipeptide bacteriocins from gram-positive bacteria. Appl Environ Microbiol, 2016, 82: 5216-5224.

[83]

Pacheco-Cano RD, De La Fuente-Salcido NM, Salcedo-Hernández R, . Characterization, N-terminal sequencing and classification of tolworthcin 524: a bacteriocin produced by Bacillus thuringiensis subsp. tolworthi. Microbiol Res, 2014, 169: 948-953.

[84]

Patrick F, Valérie L, Jean-Sébastien G, . Temperature dependence of mycosubtilin homologue production in Bacillus subtilis ATCC6633. Res Microbiol, 2008, 159: 449-457.

[85]

Pattnaik P, Kaushik JK, Grover S, Batish VK. Purification and characterization of a bacteriocin-like compound (Lichenin) produced anaerobically by Bacillus licheniformis isolated from water buffalo. J Appl Microbiol, 2001, 91: 636-645.

[86]

Pattnaik P, Grover S, Batish VK. Effect of environmental factors on production of lichenin, a chromosomally encoded bacteriocin-like compound produced by Bacillus licheniformis 26L-10/3RA. Microbiol Res, 2005, 160: 213-218.

[87]

Perumal V, Yao Z, Kim JA, . Purification and characterization of a bacteriocin, bacBS2, produced by bacillus velezensis BS2 isolated from meongge jeotgal. J Microbiol Biotechnol, 2019, 29: 1033-1042.

[88]

Phelan RW, Barret M, Cotter PD, . Subtilomycin: a new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans. Mar Drugs, 2013, 11: 1878-1898.

[89]

Pohilenko VD, Perelygin VV, Sadikova GT et al (2014) Strain Bacillus lentus—producer of bacteriocin-like substance of antimicrobial action and method of obtaining bacteriocin-like substance, Russian patents, RU2530552C1

[90]

Pokusaeva K, Kuisiene N, Jasinskyte D, . Novel bacteriocins produced by Geobacillus stearothermophilus. Cent Eur J Biol Res, 2009, 4: 196-203.

[91]

Qin Y, Wang Y, He Y, . Characterization of subtilin L-Q11, a novel class I bacteriocin synthesized by Bacillus subtilis L-Q11 isolated from orchard soil. Front Microbiol, 2019

[92]

Ratchaneewan A, Pipatsatitpong D. Isolation and characterization of a bacteriocin with anti-MRSA activity from Bacillus sp. strain WASM9-25M. Thai J Pharmacol, 2014, 36: 19-28.

[93]

Rea MC, Sit CS, Clayton E, . Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci USA, 2010, 107: 9352-9357.

[94]

Repka LM, Chekan JR, Nair SK, van der Donk WA. Mechanistic understanding of lanthipeptide biosynthetic enzymes. Chem Rev, 2017, 117: 5457-5520.

[95]

Salazar-Marroquín EL, Galán-Wong LJ, Moreno-Medina VR, . Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications. Rev Med Microbiol, 2016, 27: 95-101.

[96]

Saleem F, Ahmad S, Yaqoob Z, . Comparative study of two bacteriocins produced by representative indigenous soil bacteria. Pak J Pharm Sci, 2009, 22: 252-258.

[97]

Sandiford S. Perspectives on lantibiotic discovery—where have we failed and what improvements are required?. Expert Opin Drug Discov, 2017, 10: 315-320.

[98]

Schmitz S, Hoffmann A, Szekat C, . The lantibiotic mersacidin is peptide. Appl Environ Microbiol, 2006, 72: 7270-7277.

[99]

Scholz R, Vater J, Budiharjo A, . Amylocyclicin, a novel circular bacteriocin produced by Bacillus amyloliquefaciens FZB42. J Bacteriol, 2014, 196: 1842-1852.

[100]

Senbagam D, Gurusamy R, Senthilkumar B. Physical chemical and biological characterization of a new bacteriocin produced by Bacillus cereus NS02. Asian Pac J Trop Med, 2013, 6: 934-941.

[101]

Sharma N, Kapoor G, Gautam N, Neopaney B. Characterization of a partially purified bacteriocin of Bacillus sp. MTCC 43 isolated from Rhizosphere of radish (Raphanus sativus) & its application as a potential food biopreservative. J Sci Ind Res, 2009, 68: 881-886.

[102]

Sharma N, Kapoor R, Gautam N, Kumari R. Purification and characterization of bacteriocin produced by Bacillus subtilis R75 isolated from fermented chunks of Mung Bean (Phaseolus radiatus). Food Technol Biotechnol, 2011, 49: 169-176.

[103]

Shayesteh F, Ahmad A, Usup G. Bacteriocin production by a marine strain of Bacillus sp. Sh10: isolation, screening and optimization of culture condition. Biotechnology, 2014, 13: 273-281.

[104]

Shi Y, Bueno A, van der Donk WA. Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli. Chem Commun, 2012, 48: 10966-10968.

[105]

Singh M, Sareen D. Novel LanT associated lantibiotic clusters identified by genome database mining. PLoS ONE, 2014, 9: e91352.

[106]

Singh PK, Chittpurna A, Le Ashish C, . Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9. PLoS ONE, 2012, 7: e31498.

[107]

Somsap O, Bangrak P, Bhoopong P, Lertcanawanichakul M. Antibacterial activity and purification of bacteriocin produced by Brevibacillus laterosporus SA14 On-anong. Walailak J Sci Technol, 2016, 13: 55-65.

[108]

Spieß T, Korn SM, Kötter P, Entian K-D. Autoinduction specificities of the lantibiotics subtilin and nisin. Appl Environ Microbiol, 2015, 81: 7914-7923.

[109]

Svetoch EA, Stern NJ, Eruslanov BV, . Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins. J Food Prot, 2005, 68: 11-17.

[110]

Teng Y, Zhao W, Qian C, . Gene cluster analysis for the biosynthesis of elgicins, novel lantibiotics produced by Paenibacillus elgii B69. BMC Microbiol, 2012, 12: 45.

[111]

Tseng CC, Murni L, Han TW, . Molecular characterization and heterologous production of the bacteriocin peocin, a DNA starvation/stationary phase protection protein, from Paenibacillus ehimensis NPUST1. Molecules, 2019, 24: 2516.

[112]

van der Donk WA, Nair SK. Structure and mechanism of lanthipeptide biosynthetic enzymes. Curr Opin Struct Biol, 2014, 29: 58-66.

[113]

Van Staden ADP, Heunis T, Smith C, . Efficacy of lantibiotic treatment of Staphylococcus aureus-induced skin infections, monitored by in vivo bioluminescent imaging. Antimicrob Agents Chemother, 2016, 60: 3948-3955.

[114]

Wang G, Manns DC, Churey JJ, Worobo RW. Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361. Appl Environ Microbiol, 2014, 80: 3576-3584.

[115]

Wang J, Zhang L, Teng K, . Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol, 2014, 80: 2633-2643.

[116]

Wieckowski BM, Hegemann JD, Mielcarek A, . The PqqD homologous domain of the radical SAM enzyme ThnB is required for thioether bond formation during thurincin H maturation. FEBS Lett, 2015, 589: 1802-1806.

[117]

Xie J, Zhang R, Shang C, Guo Y. Isolation and characterization of a bacteriocin produced by an isolated Bacillus subtilis LFB112 that exhibits antimicrobial activity against domestic animal pathogens. Afr J Biotechnol, 2009, 8: 5611-5619.

[118]

Xin B, Zheng J, Xu Z, . Three novel lantibiotics, ticins A1, A3, and A4, have extremely stable properties and are promising food biopreservatives. Appl Environ Microbiol, 2015, 81: 6964-6972.

[119]

Xin B, Zheng J, Liu H, . Thusin, a novel two-component lantibiotic with potent antimicrobial activity against several Gram-positive pathogens. Front Microbiol, 2016, 7: 1-12.

[120]

Yang Y, Kim Y, Hong J, Lee C. Characterization of subtilein, a bacteriocin from Bacillus subtilis CAU131 (KCCM 10257). J Microbiol Biotechnol, 2002, 12: 228-234.

[121]

Yu Y, Zhang Q, van der Donk WA. Insights into the evolution of lanthipeptide biosynthesis. Protein Sci, 2013, 22: 1478-1489.

[122]

Yusra Y, Azima F, Novelina N, Periadnadi P. Characterization of antimicrobial bacteriocin produced by Bacillus cereus SS28 isolates from Budu, a traditionally fermented fish product of West Sumatera. Microbiol Indones, 2014, 8: 24-32.

AI Summary AI Mindmap
PDF

147

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/